TY - JOUR T1 - Infertility in systemic lupus erythematosus: what rheumatologists need to know in a new age of assisted reproductive technology JF - Lupus Science & Medicine JO - Lupus Sci Med DO - 10.1136/lupus-2022-000840 VL - 9 IS - 1 SP - e000840 AU - Bessie Stamm AU - Medha Barbhaiya AU - Caroline Siegel AU - Sarah Lieber AU - Michael Lockshin AU - Lisa Sammaritano Y1 - 2022/12/01 UR - http://lupus.bmj.com/content/9/1/e000840.abstract N2 - Fertility is often a concern for women with SLE. In addition to known indirect factors that influence the ability of a woman with SLE to become pregnant, such as cytotoxic agents, other medications, advanced age and psychosocial effects of the disease, direct disease-related factors are believed to influence fertility. These include diminished ovarian reserve, menstrual irregularities (a function of disease activity) and the presence of antiphospholipid antibodies. The question of whether SLE intrinsically affects fertility, however, remains unanswered. In this review, we address known factors affecting fertility, assess current data regarding a direct impact of SLE on fertility and evaluate potential disease-related risk factors. We focus primarily on studies measuring anti-Müllerian hormone and antral follicle count, the most widely measured markers of ovarian reserve. Our goal is to provide information to rheumatologists faced with counselling patients with SLE regarding their fertility, family planning and options for assisted reproductive technologies, which now include fertility preservation through oocyte cryopreservation. ER -